FDA Initiative Encourages Use Of Imaging Technologies To Identify Biomarkers
This article was originally published in The Pink Sheet Daily
Executive Summary
An FDA working group will develop guidance on the use of imaging to speed drug development. Locating the biomarkers will require coordination between manufacturers and the imaging industry.